| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
|
Clin Cancer Res
|
2008
|
2.37
|
|
2
|
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
|
J Thorac Oncol
|
2011
|
1.49
|
|
3
|
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
|
Histopathology
|
2009
|
1.28
|
|
4
|
Prognostic impact of lymphocytes in soft tissue sarcomas.
|
PLoS One
|
2011
|
1.06
|
|
5
|
Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.
|
Anticancer Res
|
2009
|
1.01
|
|
6
|
The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.
|
PLoS One
|
2011
|
0.99
|
|
7
|
Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
|
Lung Cancer
|
2010
|
0.97
|
|
8
|
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.
|
PLoS One
|
2011
|
0.95
|
|
9
|
Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
|
PLoS One
|
2010
|
0.94
|
|
10
|
Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.
|
BMC Urol
|
2014
|
0.92
|
|
11
|
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.
|
PLoS One
|
2011
|
0.91
|
|
12
|
Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.
|
PLoS One
|
2012
|
0.90
|
|
13
|
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome.
|
Lung Cancer
|
2011
|
0.90
|
|
14
|
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.
|
J Thorac Dis
|
2012
|
0.89
|
|
15
|
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
|
BMC Cancer
|
2014
|
0.88
|
|
16
|
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.
|
J Transl Med
|
2011
|
0.88
|
|
17
|
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas.
|
Int J Oncol
|
2011
|
0.88
|
|
18
|
Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.
|
Prostate
|
2014
|
0.88
|
|
19
|
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.
|
BMC Clin Pathol
|
2014
|
0.87
|
|
20
|
Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.
|
J Thorac Oncol
|
2009
|
0.86
|
|
21
|
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.
|
Lung Cancer
|
2013
|
0.86
|
|
22
|
Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
|
J Thorac Oncol
|
2010
|
0.84
|
|
23
|
The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.
|
APMIS
|
2010
|
0.84
|
|
24
|
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.
|
BMC Clin Pathol
|
2012
|
0.84
|
|
25
|
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
|
J Transl Med
|
2011
|
0.83
|
|
26
|
In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology.
|
Anticancer Res
|
2012
|
0.83
|
|
27
|
Correlation and coexpression of HIFs and NOTCH markers in NSCLC.
|
Anticancer Res
|
2011
|
0.82
|
|
28
|
Prognostic impacts of hypoxic markers in soft tissue sarcoma.
|
Sarcoma
|
2012
|
0.82
|
|
29
|
Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas.
|
BMC Clin Pathol
|
2013
|
0.82
|
|
30
|
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome.
|
BMC Clin Pathol
|
2014
|
0.81
|
|
31
|
Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival.
|
Sarcoma
|
2011
|
0.79
|
|
32
|
High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.
|
Oncoimmunology
|
2012
|
0.78
|
|
33
|
Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.
|
BMC Clin Pathol
|
2012
|
0.76
|
|
34
|
Centralized inpatient palliative care units in remote areas: an obstacle to future home care?
|
Palliat Med
|
2006
|
0.75
|
|
35
|
Sudden death by an atrial-esophageal fistulae.
|
J Thorac Oncol
|
2013
|
0.75
|